Support and Resistance Levels
Past performance
About Sunrest Lifescience Ltd Sunrest Lifescience Ltd, established as a private company in 2017, transitioned to a public limited company in March 2023. The company is focused on marketing OTC generic pharmaceutical products across various Indian states, including Maharashtra, Gujarat, and Rajasthan. Sunrest's diverse product range includes capsules, tablets, syrups, and more, covering therapeutic areas such as antibacterial, antifungal, anti-diabetic, and multivitamin products. They source their products primarily from Trilend Pharmaceuticals Private Limited, of which they own 9.90% equity, and collaborate with 32 third-party manufacturers across India.
Sunrest Lifescience Ltd is planning a public offer to issue up to 1,291,200 equity shares, aiming to expand its market presence. This strategic move indicates a growth-focused approach, leveraging its established network and product portfolio to enhance its market share in the competitive pharmaceutical sector.